Skip to content

Use of Millets in management of obesity

A Clinical Study of Millets [ Shyamaka (Echinochloa Frumentacea Linn.), Kodrava (Paspalum Scrobiculatum Linn) and Yavanala (Sorghum Vulgare Linn.)] in the Management Of Medovriddhi (Overweight) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067304
Enrollment
30
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Sponsors

National institute of Ayurveda Deemed to be university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: Participants aged between 20 and 60 years. 2. Overweight Status: Individuals with a BMI (Body Mass Index) ranging from 25 to 30 kg/m², indicating overweight status. 3. Health Status: Participants without any significant medical conditions, such as cardiovascular diseases, diabetes, or metabolic disorders, that may interfere with the study outcomes. 4. Weight Stability: Individuals with stable body weight (±2 kg) for at least three months before the study initiation. 5. Willingness to Comply: Participants willing to adhere to the prescribed millet-based dietary intervention for the entire study duration. 6. Ability to Give Consent: Individuals capable of providing informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1. Age and Gender: Participants having age less than 20 years or more than 60 years are Excluded. 2. BMI Status: Individuals with a BMI below 25 kg/m² (not overweight) or above 30 kg/m² (obese). 3. Medical Conditions: Participants with a history of significant medical conditions, such as heart disease, diabetes, renal disorders, or thyroid dysfunction. 4. Allergies or Intolerances: Participants with known allergies or intolerances to millets or any components of the millet-based dietary intervention. 5. Pregnancy and Lactation: Pregnant or lactating individuals, as the dietary intervention may not be suitable during these periods. 6. Participation in Other Studies: Participants currently enrolled in other clinical studies or interventions related to weight management or nutrition. 7. Medication Use: Individuals taking medications or supplements known to affect weight or metabolic parameters. 8. Uncontrolled Hypertension: Participants with uncontrolled hypertension (systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 100 mmHg). 9. Mental Health Concerns: Individuals with significant mental health conditions or eating disorders that could affect dietary adherence.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the change in body weight and BMI. after the millet-based dietary intervention. This outcome will assess the effectiveness of the millet diet in promoting weight reduction in participants with MedoVriddhi (overweight). Body weight will be measured at baseline (before the intervention) and at the end of the intervention period.Timepoint: at baseline to 2 nd week of Intervention

Secondary

MeasureTime frame
1. Body Composition 2. Metabolic Parameters 3. Adherence to the Millet Diet 4. Safety & Adverse Events 5. Changes in Quality of Life:Timepoint: at baseline to 4-6 weeks

Countries

India

Contacts

Public ContactDr. viramgama jinal khodidasbhai

National institute of Ayurveda deemed to be university ,jaipur

armurthy_2005@yahoo.com9314513659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026